Organization
CytRx Corp. ▼
Topic
All Topics ▼
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
CytRx Corp.
CytRx Corporation announces USD250,000 in milestone payment for arimoclomol from Orphazyme A/S
September 14, 2018  •  Global Banking News
... Biopharmaceutical company CytRx Corporation (NASDAQ:CYTR) reported on Thursday the receipt of a milestone payment of USD250,000 ...
CytRx Corporation Announces Receipt of Milestone Payment from Orphazyme A/S
September 13, 2018  •  PR Newswire
... CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation to Present at the H.C. Wainwright & Co. 20th Annual Global Investment Conference in New York City September 4-6, 2018
August 27, 2018  •  PR Newswire
... CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corp. filed form 10-Q
August 6, 2018  •  SEC
CytRx Corporation reports payment of balance of outstanding debt
August 2, 2018  •  Global Banking News
... Biopharmaceutical company CytRx Corporation (Nasdaq:CYTR) announced on Wednesday the completion of the final scheduled payment under ...
CytRx Corporation to Hold Second Quarter 2018 Financial Results Conference Call and Webcast on Monday, August 6, 2018
July 30, 2018  •  PR Newswire
... CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation Announces Expiration of Outstanding Warrants
July 23, 2018  •  PR Newswire
... CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation to Present at the Singular Research Summer Solstice 2018 Conference
July 16, 2018  •  PR Newswire
... CytRx Corporation (Nasdaq: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation Highlights Aldoxorubicin Included in New NantCell Inc. Triple Negative Breast Cancer Clinical Trial
June 28, 2018  •  PR Newswire
... CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today ...
CytRx Corporation Highlights Review of NantCell Inc's Aldoxorubicin Published in Future Oncology
June 21, 2018  •  PR Newswire
... CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today highlighted ...
Related News Feeds
Board and Executive Moves involving CytRx Corp.
Pharmaceuticals
Board and Executive Moves in Pharmaceuticals
Alumni of CytRx Corp.
Subscribe now for full coverage on CytRx Corp.
Start My Free Trial